First Hearing: Insulin Costs
Date: Tuesday, April 2, 2019 - 10:30am
Location: 2322 Rayburn House Office Building
Subcommittees: Oversight and Investigations (116th Congress)
The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce will hold a hearing on Tuesday, April 2, 2019, at 10:30 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled, “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs.”
Dexcom Adds “Hey Siri, what’s my glucose?" and MORE!
DEXCOM G6 MOBILE APP version 1.4.0 released!
NEW IN THE DEXCOM G6 MOBILE APP:
“Hey Siri, what’s my glucose?”* – iOS device users will now be able to ask Siri to read Dexcom glucose readings aloud and display graphs directly on the lock screen, eliminating the process of unlocking the phone and manually opening the Dexcom app; the launch of virtual assistant integration is a first-of-its-kind innovation in CGM
More followers** – Expanded Share function, allowing users to share glucose readings directly with up to ten people, versus five in the previous version; this update is critical for pediatric patients and others who rely heavily on their family and diabetes support network to help manage their disease
24-hour sensor expiration reminders – Automatically receive a 24-hour reminder before it’s time to replace a sensor, in addition to 2-hour and 6-hour reminders
CLARITY app right at your fingertips – Launch the Dexcom CLARITY app directly from the Dexcom G6 app for more retrospective glucose reports. If a customer does not yet have CLARITY, they will be taken to the App Store to download and install the app
Submit technical support inquiries – Submit technical inquiries through a browser launched through the app, versus the auto-populated email in the previous version
Apple Watch Series 4 face complication – iOS device users are offered a new Graphic Circular complication specifically for the Apple Watch Series 41
Integration with Google Fit – Android device users will have a new integration with Google Fit to display Dexcom CGM data on a 3-hour delay
Dexcom users can download the app update today from the iOS App Store and it will be available for download soon on Google Play. For more information on Dexcom G6®, please visit my link.
For complete device compatibility chart visit dexcom.com/compatibility
[1] Smart phone required to display readings on watch
[1] If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
** Separate Follow app required
*Compatible with iOS 12
Quincy the Koala uses Dexcom G6 (with video)
Koala with Diabetes at San Diego Zoo Receives Help from Dexcom G6
A group of San Diego based experts came together June 1, 2018 to help a koala with diabetes at the San Diego Zoo. The koala, a male named Quincy, has been diagnosed with type 1 diabetes.
Media release from the San Diego Zoo, Dexcom and Scripps Health
The experts, representing veterinarians, endocrinologists from Scripps Health, biotechnology professionals from Dexcom and San Diego Zoo animal care specialists took a course of action designed to better manage Quincy’s blood sugar levels through the application of a glucose monitor.
“Very few koalas have been diagnosed with and treated for diabetes. Quincy currently requires insulin injections, which are based on his blood sugar level.With a continuous glucose monitor, we may beable to monitor Quincy’s glucose levels throughout the day without having to disturb him. We are hopeful that thistechnology will work as well in koalas as it does in people, thus allowingus to optimize his insulin therapy while promoting his welfare during his illness.”
Learn more about Dexcom today!
The Dexcom G6 Continuous Glucose Monitoring System that Quincy is wearing is the latest innovation in diabetes management technology, which started shipping to people with diabetes earlier this month. The sensor and transmitter placed on Quincy sends his blood glucose levels in real time to a smart device monitored by his caretakers. With the new G6 technology, his veterinarians will no longer need to prick his skin multiple times per day to test his blood glucose levels. The Dexcom CGM also has built in alerts and alarms that will proactively notify Quincy’s caretakers before his blood glucose reaches dangerous levels.
A group of San Diego based experts came together June 1, 2018 to help a koala with diabetes at the San Diego Zoo. The koala, a male named Quincy, has been diagnosed with type 1 diabetes. Try a Dexcom CGM today - http://bit.ly/DexAd More at
“You can imagine what this technology means for Quincy,and any person trying to manage this challenging disease. Just like Quincy’s veterinarian, people with diabetes and their family or friends can monitor their glucose levels from a mobile device, providing around-the-clock safety and peace of mind.”
Koalas normally sleep during the day and are solitary animals. Animal care staff at the San Diego Zoo hope the new sensor will allow them to get more detail about Quincy’s glucose levels while also reducing the number of times they need to disturb him. "Quincy has an insulin deficiency type of diabetes, and needs insulin to control his blood sugar levels and ensure he gets the energy needed to help him build muscle, gain weight and stay healthy much like our human patients," said Athena Philis Tsimikas, M.D., corporate vice president of the Scripps Whittier Diabetes Institute. "Hypoglycemia abnormally low blood sugar is a safety concern, and the limiting factor to using the right doses of insulin, especially in an animal that can’t tell us their symptoms. The continuous glucose monitoring now allows optimal dosing to best manage Quincy’s diabetes." The application of the monitor went smoothly, and animal care staff said they look forward to having information that will help them develop a treatment plan to improve Quincy’s condition. Quincy’s diabetic condition was initially diagnosed by veterinarians at the Los Angeles Zoo, where Quincy was living at the time. He was transferred to the San Diego Zoo for continued advanced diagnosis and treatment. Diabetes has rarely been documented in koalas, and animal care experts do not know what may have triggered this condition in Quincy.
Dexcom G6 APPROVED by FDA: All the pics and video are here
The Dexcom G6 Continuous Glucose Monitor has been approved by the FDA!
I have so much media to share with you but before you dive in here are some things that you can look forward to:
- Zero fingersticks – No fingersticks needed for calibration or diabetes treatment decisions
- One-touch applicator – Redesigned one-touch applicator that is virtually painless
- Low-profile wearable – New transmitter with a 28 percent lower profile for comfortable wear
- Mobile compatibility – Compatibility with smart device apps to display and share glucose information with up to five people
- Alerts and alarms – Customizable alerts and alarms to proactively warn users of pending dangerous high and low blood sugars
If you have any questions for Dexcom about the new G6 please leave them in the comment section. Okay, have fun with he pics and video!
WATCH: G6 Product Video
PICS: Scroll and smile
Excited? Get your Dexcom today!
Dexcom Opens their API to Third-party Developers
Dexcom leads the way in diabetes yet again...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (CGM), announced today the availability of a public API, empowering third-party developers to connect patient-authorized CGM data into a broad range of software applications. This pioneering approach to CGM data sharing is intended to enable a rich ecosystem of novel solutions and put the user in control of where and how they interact with their glucose data.
"In launching this developer platform, Dexcom combines our CGM data expertise with the creativity of the developer ecosystem to enable new solutions and business models in the treatment and management of diabetes," said Annika Jimenez, Senior Vice President of Data, Dexcom. "Dexcom believes in data mobility and customer choice. It also believes that the API opens up opportunities to drive Dexcom CGM data into the heart of new digital solutions for payers, providers, and most importantly people with diabetes."